ZIMV ZimVie
- 15.800
- -0.030-0.19%
- 16.210
- +0.410+2.59%
ZimVie News
Former ZimVie Exec Rebecca Whitney Named CEO of Highridge Medical
ZimVie to Report First Quarter Financial Results on May 8, 2024
PALM BEACH GARDENS, Fla., April 24, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (NASDAQ:ZIMV), a global life sciences leader in the dental market, today announced it will report financial results for the first quarter 2024
Express News | Needham Reiterates Hold on ZimVie
Analysts Have Conflicting Sentiments on These Healthcare Companies: ZimVie Inc (ZIMV) and Merus (MRUS)
Express News | ZimVie Shares Are Trading Higher After the Company Closed the Sale of Its Spine Business to an Affiliate of H.I.G. Capital for $375 Million
Micron, Iris Energy, Trip.com Group And Other Big Stocks Moving Higher On Monday
U.S. stocks were lower, with the Dow Jones falling around 250 points on Monday. Shares of Micron Technology, Inc. (NASDAQ:MU) rose sharply during Monday's session after B of A Securities maintained a
ZimVie Expects To Achieve An Annualized Financial Profile Of $455M+ In Net Sales Vs $454.05M Est.; A 15%+ Adjusted EBITDA Margin 1-Year Following The Close Of The Deal
Outlook for ZimVieAs previously communicated, ZimVie expects to achieve an annualized financial profile of $455+ million in Net Sales, and a 15%+ adjusted EBITDA margin(1) one year following the close
ZimVie Closes Sale Of Spine Business, Reaffirms Annual Sales View; Stock Up Over 5%
H.I.G. Capital Completes Acquisition of the Spine Unit of ZimVie
ZimVie Announces Closing of Sale of Spine Business
Completion of Sale to an Affiliate of H.I.G. Capital for $375 Million Establishes Pure-Play Dental BusinessPALM BEACH GARDENS, Fla., April 01, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a
ZimVie to Participate in the 23rd Annual Needham Virtual Healthcare Conference
WESTMINSTER, Colo., March 27, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced management will participate in the u
Multiple Reasons for the Surge of ZimVie (ZIMV) in Q4
Spinal Non-Fusion Market Forecast to 2033, by Segments, Share, Regulatory, Reimbursement, Procedures and Company Coverage of Medtronic, ZimVie, Globus Medical, Centinel Spine and Paradigm Spine
DUBLIN, March 8, 2024 /PRNewswire/ -- The "Spinal Non-Fusion Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033" report has been added to ResearchAndMarkets.co
ZimVie Is Maintained at Underweight by Barclays
ZimVie Is Maintained at Underweight by Barclays
Express News | Barclays Maintains Underweight on ZimVie, Raises Price Target to $16
ZimVie Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 03/05/2024 -6.71% Barclays $13 → $16 Maintains Underweight 01/04/2024 -24.2% Barclays $11 → $13 Maintains
Analysts Offer Insights on Healthcare Companies: Ginkgo Bioworks Holdings (DNA), ZimVie Inc (ZIMV) and Veeva Systems (VEEV)
Earnings Call: ZimVie Eyes Growth Post-Spine Business Sale, Despite Sales Dip
It's A Story Of Risk Vs Reward With ZimVie Inc. (NASDAQ:ZIMV)
You may think that with a price-to-sales (or "P/S") ratio of 1x ZimVie Inc. (NASDAQ:ZIMV) is definitely a stock worth checking out, seeing as almost half of all the Medical Equipment companies in the
Earnings Call Summary | ZimVie(ZIMV.US) Q4 2023 Earnings Conference
The following is a summary of the ZimVie Inc. (ZIMV) Q4 2023 Earnings Call Transcript:Financial Performance:ZimVie Inc.'s Q4 2023 total third-party net sales were $113.1 million, a decrease of 2.4% in
Analysis
Price Target
No Data
